HUT72440A
(en)
*
|
1994-03-31 |
1996-04-29 |
Bristol Myers Squibb Co |
Imidazole-containing inhibitors of farnesyl protein transferase and pharmaceutical compositions containing them
|
IT1273986B
(it)
*
|
1994-09-28 |
1997-07-14 |
Merck & Co Inc |
Inibitori peptidici di farnesil proteina transferasi
|
US5661161A
(en)
*
|
1994-09-29 |
1997-08-26 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
US5652257A
(en)
*
|
1994-09-29 |
1997-07-29 |
Merck & Co., Inc. |
Heterocycle-containing inhibitors of farnesyl-protein transferase
|
CA2204144A1
(en)
*
|
1994-12-09 |
1996-06-13 |
Francis J. Tinney |
Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase
|
US5856326A
(en)
*
|
1995-03-29 |
1999-01-05 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
US5627202A
(en)
*
|
1995-03-29 |
1997-05-06 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
US5631280A
(en)
*
|
1995-03-29 |
1997-05-20 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
US5534537A
(en)
*
|
1995-03-29 |
1996-07-09 |
Merck & Co., Inc. |
Prodrugs of inhibitors of farnesyl-protein transferase
|
US5624936A
(en)
*
|
1995-03-29 |
1997-04-29 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
US5578629A
(en)
*
|
1995-03-29 |
1996-11-26 |
Merck & Co., Inc. |
Benzamide-containing inhibitors of farnesyl-protein transferase
|
US5710171A
(en)
*
|
1995-05-24 |
1998-01-20 |
Merck & Co., Inc. |
Bisphenyl inhibitors of farnesyl-protein transferase
|
US5972984A
(en)
*
|
1995-06-06 |
1999-10-26 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
US5756528A
(en)
*
|
1995-06-06 |
1998-05-26 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
GB9517060D0
(en)
*
|
1995-08-17 |
1995-10-25 |
Ciba Geigy Ag |
Acylated oligopeptide derivatives
|
US5703241A
(en)
*
|
1995-10-16 |
1997-12-30 |
Merck & Co., Inc. |
Inhibitor of farnesyl-protein transferase
|
US6117641A
(en)
|
1996-04-11 |
2000-09-12 |
Mitotix, Inc. |
Assays and reagents for identifying anti-fungal agents and uses related thereto
|
DE69713759T2
(de)
|
1996-04-11 |
2003-03-13 |
Mitotix Inc |
Assays und reaganzien zur identifizierung von fungiziden wirkstoffen und ihre verwendungen
|
US6727082B1
(en)
|
1996-04-11 |
2004-04-27 |
Gpc Biotech Inc. |
Assays and reagents for identifying anti-fungal agents, and uses related thereto
|
US6307090B1
(en)
|
1999-01-22 |
2001-10-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Acylated oligopeptide derivatives having cell signal inhibiting activity
|
JP4604161B2
(ja)
|
1999-03-23 |
2010-12-22 |
アメリカ合衆国 |
フェニルアラニン誘導体
|
US7226991B1
(en)
|
1999-03-23 |
2007-06-05 |
United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Phenylalanine derivatives
|
US7871981B2
(en)
|
1999-10-22 |
2011-01-18 |
The United States Of America As Represented By The Department Of Health And Human Services |
Inhibition of cell motility, angiogenesis, and metastasis
|
ATE362767T1
(de)
|
1999-10-22 |
2007-06-15 |
Us Gov Health & Human Serv |
Hemmung der zellmotilität und angiogenese mit grb2 sh2-domäne inhibitoren
|
US7425537B2
(en)
|
2000-08-22 |
2008-09-16 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
SH2 domain binding inhibitors
|
US6977241B2
(en)
|
2000-08-22 |
2005-12-20 |
The United States Of America As Represented By The Department Of Health & Human Services |
SH2 domain binding inhibitors
|
US20050119163A1
(en)
|
2003-09-18 |
2005-06-02 |
The Government Of The United States Of America, As Represented By The Secretary, |
SH2 domain binding inhibitors
|
US8362075B2
(en)
|
2005-05-17 |
2013-01-29 |
Merck Sharp & Dohme Corp. |
Cyclohexyl sulphones for treatment of cancer
|
GB0603041D0
(en)
|
2006-02-15 |
2006-03-29 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
EA018917B1
(ru)
|
2006-04-19 |
2013-11-29 |
Новартис Аг |
6-о-замещенные бензоксазолы и бензотиазолы и способы подавления передачи сигналов от csf-1r
|
CA2664113C
(en)
|
2006-09-22 |
2013-05-28 |
Merck & Co., Inc. |
Use of platencin and platensimycin as fatty acid synthesis inhibitors to treat obesity, diabetes and cancer
|
US20110218176A1
(en)
|
2006-11-01 |
2011-09-08 |
Barbara Brooke Jennings-Spring |
Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
|
PL2805945T3
(pl)
|
2007-01-10 |
2019-09-30 |
Msd Italia S.R.L. |
Indazole podstawione grupą amidową jako inhibitory polimerazy poli(adp-rybozy) - (parp)
|
KR101514853B1
(ko)
|
2007-03-01 |
2015-04-24 |
노파르티스 아게 |
Pim 키나제 억제제 및 이들의 사용 방법
|
ES2452349T3
(es)
|
2007-05-21 |
2014-04-01 |
Novartis Ag |
Inhibidores de CSF-1R, composiciones, y métodos de uso
|
WO2009002495A1
(en)
|
2007-06-27 |
2008-12-31 |
Merck & Co., Inc. |
4-carboxybenzylamino derivatives as histone deacetylase inhibitors
|
WO2010114780A1
(en)
|
2009-04-01 |
2010-10-07 |
Merck Sharp & Dohme Corp. |
Inhibitors of akt activity
|
US8765747B2
(en)
|
2009-06-12 |
2014-07-01 |
Dana-Farber Cancer Institute, Inc. |
Fused 2-aminothiazole compounds
|
UA109417C2
(uk)
|
2009-10-14 |
2015-08-25 |
Мерк Шарп Енд Доме Корп. |
ЗАМІЩЕНІ ПІПЕРИДИНИ, ЯКІ ПІДВИЩУЮТЬ АКТИВНІСТЬ p53, І ЇХ ЗАСТОСУВАННЯ
|
US9180127B2
(en)
|
2009-12-29 |
2015-11-10 |
Dana-Farber Cancer Institute, Inc. |
Type II Raf kinase inhibitors
|
US8987275B2
(en)
|
2010-03-16 |
2015-03-24 |
Dana-Farber Cancer Institute, Inc. |
Indazole compounds and their uses
|
US8999957B2
(en)
|
2010-06-24 |
2015-04-07 |
Merck Sharp & Dohme Corp. |
Heterocyclic compounds as ERK inhibitors
|
US8518907B2
(en)
|
2010-08-02 |
2013-08-27 |
Merck Sharp & Dohme Corp. |
RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)
|
EP4079856A1
(de)
|
2010-08-17 |
2022-10-26 |
Sirna Therapeutics, Inc. |
Rna-interferenz-vermittelte hemmung der hepatitis b-virus (hbv)-genexpression mittels kurzer interferierender nukleinsäure (sina)
|
EP2608669B1
(de)
|
2010-08-23 |
2016-06-22 |
Merck Sharp & Dohme Corp. |
Neue pyrazolo-[1,5-a-]pyrimidinderivate als mtor-hemmer
|
US8946216B2
(en)
|
2010-09-01 |
2015-02-03 |
Merck Sharp & Dohme Corp. |
Indazole derivatives useful as ERK inhibitors
|
US9242981B2
(en)
|
2010-09-16 |
2016-01-26 |
Merck Sharp & Dohme Corp. |
Fused pyrazole derivatives as novel ERK inhibitors
|
WO2012058210A1
(en)
|
2010-10-29 |
2012-05-03 |
Merck Sharp & Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACIDS (siNA)
|
WO2012087772A1
(en)
|
2010-12-21 |
2012-06-28 |
Schering Corporation |
Indazole derivatives useful as erk inhibitors
|
CA2833009A1
(en)
|
2011-04-21 |
2012-10-26 |
Merck Sharp & Dohme Corp. |
Insulin-like growth factor-1 receptor inhibitors
|
US9023865B2
(en)
|
2011-10-27 |
2015-05-05 |
Merck Sharp & Dohme Corp. |
Compounds that are ERK inhibitors
|
WO2013074986A1
(en)
|
2011-11-17 |
2013-05-23 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of c-jun-n-terminal kinase (jnk)
|
WO2013165816A2
(en)
|
2012-05-02 |
2013-11-07 |
Merck Sharp & Dohme Corp. |
SHORT INTERFERING NUCLEIC ACID (siNA) COMPOSITIONS
|
MX2015004041A
(es)
|
2012-09-28 |
2015-07-06 |
Merck Sharp & Dohme |
Compuestos novedosos que son inhibidores de erk.
|
WO2014063068A1
(en)
|
2012-10-18 |
2014-04-24 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinase 7 (cdk7)
|
WO2014063061A1
(en)
|
2012-10-19 |
2014-04-24 |
Dana-Farber Cancer Institute, Inc. |
Hydrophobically tagged small molecules as inducers of protein degradation
|
US10000483B2
(en)
|
2012-10-19 |
2018-06-19 |
Dana-Farber Cancer Institute, Inc. |
Bone marrow on X chromosome kinase (BMX) inhibitors and uses thereof
|
CA2892361A1
(en)
|
2012-11-28 |
2014-06-05 |
Merck Sharp & Dohme Corp. |
Use of a wee1 inhibitor for treating a cancer characterized by low pkmyt1 expression levels
|
RU2690663C2
(ru)
|
2012-12-20 |
2019-06-05 |
Мерк Шарп И Доум Корп. |
Замещенные имидазопиридины в качестве ингибиторов hdm2
|
WO2014120748A1
(en)
|
2013-01-30 |
2014-08-07 |
Merck Sharp & Dohme Corp. |
2,6,7,8 substituted purines as hdm2 inhibitors
|
US20160194368A1
(en)
|
2013-09-03 |
2016-07-07 |
Moderna Therapeutics, Inc. |
Circular polynucleotides
|
CA2927917C
(en)
|
2013-10-18 |
2022-08-09 |
Syros Pharmaceuticals, Inc. |
Heteroaromatic compounds useful for the treatment of proliferative diseases
|
AU2014337044A1
(en)
|
2013-10-18 |
2016-05-05 |
Dana-Farber Cancer Institute, Inc. |
Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)
|
US9862688B2
(en)
|
2014-04-23 |
2018-01-09 |
Dana-Farber Cancer Institute, Inc. |
Hydrophobically tagged janus kinase inhibitors and uses thereof
|
WO2015164614A1
(en)
|
2014-04-23 |
2015-10-29 |
Dana-Farber Cancer Institute, Inc. |
Janus kinase inhibitors and uses thereof
|
JO3589B1
(ar)
|
2014-08-06 |
2020-07-05 |
Novartis Ag |
مثبطات كيناز البروتين c وطرق استخداماتها
|
WO2016105528A2
(en)
|
2014-12-23 |
2016-06-30 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinase 7 (cdk7)
|
EP3273966B1
(de)
|
2015-03-27 |
2023-05-03 |
Dana-Farber Cancer Institute, Inc. |
Hemmer von cyclinabhängigen kinasen
|
CA2986441A1
(en)
|
2015-06-12 |
2016-12-15 |
Dana-Farber Cancer Institute, Inc. |
Combination therapy of transcription inhibitors and kinase inhibitors
|
EP3347018B1
(de)
|
2015-09-09 |
2021-09-01 |
Dana-Farber Cancer Institute, Inc. |
Hemmer von cyclinabhängigen kinasen
|
JOP20190055A1
(ar)
|
2016-09-26 |
2019-03-24 |
Merck Sharp & Dohme |
أجسام مضادة ضد cd27
|
SG11201908813QA
(en)
|
2017-04-13 |
2019-10-30 |
Aduro Biotech Holdings Europe B V |
Anti-sirp alpha antibodies
|
EP3706742B1
(de)
|
2017-11-08 |
2023-03-15 |
Merck Sharp & Dohme LLC |
Prmt5-inhibitoren
|
US10311444B1
(en)
|
2017-12-02 |
2019-06-04 |
M-Fire Suppression, Inc. |
Method of providing class-A fire-protection to wood-framed buildings using on-site spraying of clean fire inhibiting chemical liquid on exposed interior wood surfaces of the wood-framed buildings, and mobile computing systems for uploading fire-protection certifications and status information to a central database and remote access thereof by firefighters on job site locations during fire outbreaks on construction sites
|
WO2019148412A1
(en)
|
2018-02-01 |
2019-08-08 |
Merck Sharp & Dohme Corp. |
Anti-pd-1/lag3 bispecific antibodies
|
EP3833667B1
(de)
|
2018-08-07 |
2024-03-13 |
Merck Sharp & Dohme LLC |
Prmt5-inhibitoren
|
WO2020033282A1
(en)
|
2018-08-07 |
2020-02-13 |
Merck Sharp & Dohme Corp. |
Prmt5 inhibitors
|